Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Inhibition of RNA polymerase I transcription initiation by CX-5461 activates non-canonical ATM/ATR signaling

6 Jul 2016

Abstract excerpt

// Jaclyn Quin 1, 2, 11 , Keefe T. Chan 1 , Jennifer R. Devlin 1, 12 , Donald P. Cameron 1, 3 , Jeannine Diesch 1, 13 , Carleen Cullinane 1 , Jessica Ahern 1 , Amit Khot 1 , Nadine Hein 4 , Amee J. George 4, 5, 6 , Katherine M Hannan 2, 4 , Gretchen Poortinga 1, 7 , Karen E. Sheppard 1, 2, 3 , Kum Kum Khanna 8 , Ricky W. Johnstone 1, 3, 5 , Denis Drygin 9 , Grant A. McArthur 1, 3, 5, 7 , Richard B. Pearson 1, 2,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related Molecular Pathways
Share to Cell death mechanisms and regulation
Share to DNA Repair Mechanisms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27391441
DOI: 10.18632/oncotarget.10452

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Inhibition of RNA polymerase I transcription initiation by CX-5461 activates non-canonical ATM/ATR signalingPMID 27391441Read ↗

The novel RNA polymerase I transcription inhibitor PMR-116 exploits a critical therapeutic vulnerability in a broad-spectrum of high <i>MYC</i> malignanciesSemantic proximity Read ↗

Impact of RNA polymerase I inhibitor CX-5461 on viral kinase-dependent and -independent cytomegalovirus replicationSemantic proximity Read ↗

RNA Polymerase I Inhibition with CX-5461 as a Novel Therapeutic Strategy to Target MYC in Multiple Myeloma.Semantic proximity Read ↗

CX-5461 Inhibits Pancreatic Ductal Adenocarcinoma Cell Growth, Migration and Induces DNA DamageSemantic proximity Read ↗

ALK signalling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibitionSemantic proximity Read ↗

CX-5461 Treatment Leads to Cytosolic DNA-Mediated STING Activation in Ovarian CancerSemantic proximity Read ↗

Inhibition of Pol I transcription treats murine and human AML by targeting the leukemia-initiating cell populationSemantic proximity Read ↗

DNA damage regulates alternative splicing through inhibition of RNA polymerase II elongation.Semantic proximity Read ↗

Novel RNA Polymerase I and Cyclin Dependent Kinase combination therapy for the treatment of aggressive Acute Myeloid LeukemiaSemantic proximity Read ↗

ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibitionSemantic proximity Read ↗

Targeting the ribosome to treat multiple myelomaSemantic proximity Read ↗

Molecular basis of CX-5461-induced DNA damage response in primary vascular smooth muscle cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.